# Hound Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hound-labs

- Industry: Medical Devices & Equipment
- Headquarters: Oakland, US
- Website: www.houndlabs.com
- Total disclosed funding: $38M
- Latest round: Series D (Aug 27, 2019)
- Investors on record: 5

## About

Hound Labs, Inc. is a US-based company specializing in innovative breathalyzer technology that detects THC levels, addressing the increasing need for reliable drug testing solutions across various sectors.Founded in 2014 and headquartered in Oakland, US, Hound Labs, Inc. develops advanced breathalyzer technology. The company has successfully completed 6 deals, with its latest funding round occurring on September 3, 2021, where it raised USD 20.00 mn led by Entourage Effect Capital, alongside other notable investors. The CEO is Mike Lynn, and the company was co-founded by Jenny L.Hound Labs specializes in developing innovative breathalyzer technology that enables the detection of THC (tetrahydrocannabinol) to address the growing need for reliable drug testing in various industries. Their flagship product, the Hound® Marijuana Breathalyzer, accurately measures an individual’s THC levels through breath samples, differentiating between recent use and past consumption. This product aims to enhance workplace safety and public health by providing law enforcement, employers, and agencies with a tool to enforce drug policies without the ambiguity associated with traditional testing methods. Hound Labs targets clients including law enforcement agencies, employers in safety-sensitive industries, and organizations focused on public health, primarily within the United States and Canada, where regulations around marijuana use are evolving.Hound Labs generates revenue primarily through direct sales of its breathalyzer units and associated testing services to businesses and government agencies. Transactions typically occur through a B2B model, where clients purchase equipment outright or enter into partnerships for ongoing service agreements. The pricing structure accommodates various client needs, offering tiered pricing based on the volume of units purchased and additional services provided. This approach allows clients, such as employers in construction or transportation, to implement comprehensive drug testing solutions tailored to their operational requirements. The company’s revenue model emphasizes the sale of its flagship products, including ancillary revenues from training and support services related to the use of their technology.In September 2021, Hound Labs, Inc. raised USD 20.00 mn in venture funding to expand its sales, marketing, and manufacturing teams to meet the growing demand for the Hound® marijuana breathalyzer. The company plans to further develop its product line and enter new markets, specifically targeting regions where marijuana regulations are evolving. This funding will facilitate the capacity to accelerate production and enhance marketing efforts to broaden its reach into additional geographic areas.

## Funding rounds

- Series D, Aug 27, 2019, $30M — Benchmark, Icon Ventures, Intrinsic Capital Partners, Main Street Advisors, NFP Ventures
- Series B, May 12, 2017, $8.1M — Benchmark

## Investors

- Benchmark (https://capitalatlas.ai/funds/benchmark) — Series B, Series D
- Icon Ventures (https://capitalatlas.ai/funds/icon-ventures) — Series D
- Intrinsic Capital Partners (https://capitalatlas.ai/funds/intrinsic-capital-partners) — Series D
- Main Street Advisors (https://capitalatlas.ai/funds/main-street-advisors) — Series D
- NFP Ventures (https://capitalatlas.ai/funds/nfp-ventures) — Series D